What did @biohackwithbails actually say?
The creator walked through a personal peptide stack using food code names, describing specific dosing schedules for each compound. She uses coded language throughout, referring to peptides as ingredients in a recipe. The stack she describes includes what appears to be CJC-1295 or ipamorelin ("Ratatouille," twice weekly), AOD-9604 ("AOD," five days on, two off), KPV (mentioned separately from "Glo"), a compound she calls "carved," and what sounds like MK-677 ("Mozzarella" or "Mazzi"), used sparingly on a two-weeks-on, two-weeks-off monthly cycle. She frames all of this as personal experience, repeating that schedules are "based on my own experience and my own journey." That framing is worth noting, but it does not neutralize the influence of presenting a specific multi-peptide protocol to 12,000 viewers.
Does the science back this up?
Some of the cycling logic she describes has a basis in peptide pharmacology, but the evidence is thin, mostly preclinical, and the specific schedules she uses are not derived from published clinical trials. They are community convention at best.
The idea of cycling peptides that affect growth hormone secretion, like CJC-1295 or ipamorelin, has biological rationale. Continuous stimulation of growth hormone-releasing hormone receptors can lead to receptor desensitization. Walker et al. (2004, Growth Hormone and IGF Research) demonstrated that pulsatile GH secretion patterns matter for downstream IGF-1 response, which is part of why pulsatile dosing protocols circulate in clinical and biohacking circles.
AOD-9604, which is a fragment of human growth hormone (hGH 176-191), has been studied primarily for fat metabolism. Ng et al. (2000, Molecular and Cellular Endocrinology) found lipolytic activity in animal models, but no large-scale human RCTs support the five-days-on protocol she describes.
KPV, a tripeptide derived from alpha-MSH, has shown anti-inflammatory activity in gut models (Dalmasso et al., 2008, Peptides), but human dosing data is essentially nonexistent. MK-677 (ibutamoren), likely the "Mozzarella" compound, has actual human trial data. Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed sustained GH and IGF-1 elevation with daily use, but also documented increased appetite, fluid retention, and insulin resistance concerns with longer-term use. Her cycling approach for MK-677 is more conservative than many protocols online, which is worth acknowledging.
What did they get wrong (or right)?
She gets partial credit for the MK-677 caution. Saying she only uses it "very sparingly" and takes extended breaks is more responsible than the "run it year-round" advice that dominates peptide communities. MK-677 has real data behind both its effects and its side effect profile, so treating it as something that needs cycling is reasonable.
What she gets wrong, or at least incomplete, is presenting a multi-compound peptide stack as a coherent personal protocol without any discussion of contraindications, monitoring, or the fact that most of these compounds are not FDA-approved for human use. AOD-9604 lost its FDA investigational new drug status after clinical trials did not support obesity treatment. KPV has no human safety data. Stacking multiple peptides that influence the GH axis simultaneously carries interaction risks that are simply not discussed here.
The code-name system is also worth naming directly. Using food terms to describe pharmaceutical compounds in a public health video obscures what is actually being recommended and makes it harder for viewers to research what they are considering putting in their bodies.
What should you actually know?
Peptide dosing schedules shared on TikTok are not clinical protocols. They are anecdotes that spread because the platform rewards relatability and confidence, not rigor. The schedules described in this video may work for the creator. That tells you almost nothing about whether they will work for you, or whether they are safe for you specifically.
Most peptides discussed in optimization and biohacking content are either research chemicals, compounded preparations without FDA-approved equivalents, or compounds that failed clinical development. That does not automatically make them dangerous, but it does mean the safety and efficacy data that would normally inform a dosing schedule does not exist at the level needed to make public recommendations.
If you are considering peptide therapy, the starting point should be a licensed provider who can review your bloodwork, assess your health history, and monitor you over time. A TikTok schedule built around another person's response to compounds they are calling "Ratatouille" is not a substitute for that. The creator repeatedly says this is her own experience, and that qualifier deserves to be taken seriously, not as a permission slip to copy the protocol.